SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Momenta Pharmaceuticals Inc. -- Ignore unavailable to you. Want to Upgrade?

To: tuck who wrote (2963)4/4/2014 5:39:39 PM
From: DewDiligence_on_SI  Read Replies (1) | Respond to of 3027
 
Musings on 3xW Copaxone’s commercial uptake from an industry insider: siliconinvestor.com



To: tuck who wrote (2963)4/7/2014 1:19:08 PM
From: mopgcw  Respond to of 3027
 
With the mEnox revenue stream a trickle compared to the burn, it's hard to tell where the floor should be . . . If it breaks into the single digits, I think I will pull the trigger.

I think the floor could be the $6-$7 on the downside ugly scenario. And I too am a buyer in the single digits.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News